InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Bachbla post# 124649

Saturday, 04/30/2016 10:11:55 PM

Saturday, April 30, 2016 10:11:55 PM

Post# of 130501
Had management stuck to the original plan of getting CLIA for Lympro, and sticking with Eltoprazine, and MANF keeping pipeline small would have been good. With no money, why branch out to terrible stuff like MSprecise, ESS. Just keep pipeline small since the company doesn't have a lot of money. The CEO is totally clueless.